Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor - PubMed (original) (raw)
. 1995 Jun:108 ( Pt 6):2369-79.
doi: 10.1242/jcs.108.6.2369.
Affiliations
- PMID: 7673356
- DOI: 10.1242/jcs.108.6.2369
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
W G Roberts et al. J Cell Sci. 1995 Jun.
Abstract
The vascular endothelial growth factor (VEGF) was originally described as vascular permeability factor due to its ability to increase microvascular permeability to plasma proteins. However, the vessel types (arteriolar, venular, and capillary) affected by VEGF and the modification of endothelial morphology in response to increased permeability induced by VEGF in vivo have not been precisely documented. By topical application or intradermal injection of recombinant human VEGF-165 we find that VEGF increases the permeability of postcapillary venules as well as muscular venules and capillaries. Surprisingly, we also find that endothelia of small venules and capillaries become fenestrated within 10 minutes of VEGF application. Fenestrations appeared in vascular beds which do not normally have fenestrated endothelium, namely the cremaster muscle and skin. Histamine, saline, and heat-inactivated VEGF do not cause fenestrations. Increased permeability is completely inhibited when VEGF is cleared by immunoprecipitation with anti-VEGF monoclonal antibodies. The VEGF effect on permeability is unlike that of any other mediator described to date since both muscular venules and capillaries are affected.
Similar articles
- Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability.
Eriksson A, Cao R, Roy J, Tritsaris K, Wahlestedt C, Dissing S, Thyberg J, Cao Y. Eriksson A, et al. Circulation. 2003 Mar 25;107(11):1532-8. doi: 10.1161/01.cir.0000055324.34758.32. Circulation. 2003. PMID: 12654612 - Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin.
Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM. Feng D, et al. J Exp Med. 1996 May 1;183(5):1981-6. doi: 10.1084/jem.183.5.1981. J Exp Med. 1996. PMID: 8642308 Free PMC article. - Neovasculature induced by vascular endothelial growth factor is fenestrated.
Roberts WG, Palade GE. Roberts WG, et al. Cancer Res. 1997 Feb 15;57(4):765-72. Cancer Res. 1997. PMID: 9044858 - Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators.
Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM. Feng D, et al. Microcirculation. 1999 Mar;6(1):23-44. Microcirculation. 1999. PMID: 10100187 Review. - Vascular effects of exercise: endothelial adaptations beyond active muscle beds.
Padilla J, Simmons GH, Bender SB, Arce-Esquivel AA, Whyte JJ, Laughlin MH. Padilla J, et al. Physiology (Bethesda). 2011 Jun;26(3):132-45. doi: 10.1152/physiol.00052.2010. Physiology (Bethesda). 2011. PMID: 21670160 Free PMC article. Review.
Cited by
- Endothelial progenitor cells in the host defense response.
Shi X, Seidle KA, Simms KJ, Dong F, Chilian WM, Zhang P. Shi X, et al. Pharmacol Ther. 2023 Jan;241:108315. doi: 10.1016/j.pharmthera.2022.108315. Epub 2022 Nov 24. Pharmacol Ther. 2023. PMID: 36436689 Free PMC article. Review. - Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeability.
Katz MG, Fargnoli AS, Bridges CR. Katz MG, et al. Hum Gene Ther. 2013 Apr;24(4):375-92. doi: 10.1089/hum.2012.241. Epub 2013 Apr 1. Hum Gene Ther. 2013. PMID: 23427834 Free PMC article. Review. - Vascular permeability--the essentials.
Claesson-Welsh L. Claesson-Welsh L. Ups J Med Sci. 2015;120(3):135-43. doi: 10.3109/03009734.2015.1064501. Epub 2015 Jul 29. Ups J Med Sci. 2015. PMID: 26220421 Free PMC article. Review. - Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease.
Turner RJ, Eikmans M, Bajema IM, Bruijn JA, Baelde HJ. Turner RJ, et al. PLoS One. 2016 Sep 6;11(9):e0162166. doi: 10.1371/journal.pone.0162166. eCollection 2016. PLoS One. 2016. PMID: 27598902 Free PMC article. - Angiogenic inhibitor pre-administration improves the therapeutic effects of immunotherapy.
Sato M, Maishi N, Hida Y, Yanagawa-Matsuda A, Alam MT, Sakakibara-Konishi J, Nam JM, Onodera Y, Konno S, Hida K. Sato M, et al. Cancer Med. 2023 Apr;12(8):9760-9773. doi: 10.1002/cam4.5696. Epub 2023 Feb 19. Cancer Med. 2023. PMID: 36808261 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources